Bollcoin, October 28: According to Anthropic's official blog, over the past few months its scientists have carried out in-depth research collaborations with six drug R&D organizations — BigHat Biosciences, Bristol Myers Squibb, Divergence Labs, Enveda, Generate Biomedicines and The Column Group — and have also launched drug discovery work of its own. At Generate Biomedicines, six scientists used Claude Code to propose new designs for some of the genetic instructions in CAR-T cell therapy; one design is about 70% shorter than the standard version and, in laboratory tests, enabled immune cells to produce about 10 times as many receptors, killing tumor cells more efficiently.